Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Fred A. Middleton | Director | 2024-12-06 | 4,800 | $2.65 | $12.72kBuy |
Robert N. Wilson | Director | 2024-11-01 | 53,333 | $3.75 | $200.00kBuy |
A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | 2024-11-01 | 20,000 | $3.75 | $75.00kBuy |
Fred A. Middleton | Director | 2024-11-01 | 877 | $3.75 | $3.29kBuy |
Fred A. Middleton | Director | 2024-11-01 | 86,867 | $3.75 | $325.75kBuy |
Fred A. Middleton | Director | 2024-11-01 | 20,000 | $3.75 | $75.00kBuy |
Sanderling Venture Partners VI Co Investment Fund LP | 10% Owner | 2024-11-01 | 86,867 | $3.75 | $325.75kBuy |
Eric W. Roberts | CHIEF BUSINESS OFFICER | 2024-11-01 | 53,333 | $3.75 | $200.00kBuy |
Sanderling Venture Partners VI Co Investment Fund LP | 10% Owner | 2024-11-01 | 877 | $3.75 | $3.29kBuy |
Michael J. Dunn | President and COO | 2024-09-09 | 11,761 | $1.39 | $16.35kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
James E. Flynn | 39.18% | 5,281,713 | $8.19M | Insider |
Orbimed Advisors LLC | 30.88% | 4,163,347 | $6.45M | Insider |
Fred A. Middleton | 23.40% | 3,155,250 | $4.89M | Insider |
Sanderling Venture Partners VI Co Investment Fund LP | 17.85% | 2,407,172 | $3.73M | Insider |
Sanderling Venture Partners VI LP | 17.20% | 2,319,428 | $3.60M | Insider |
Clarus Lifesciences III LP | 14.32% | 1,930,395 | $2.99M | Insider |
Christy L. Shaffer | 11.92% | 1,606,669 | $2.49M | Insider |
Deerfield Management Company LP Series C | 9.64% | 1,300,000 | $2.02M | Institution |
Hansoo Michael Keyoung | 8.41% | 1,133,596 | $1.76M | Insider |
Eric W. Roberts | 7.23% | 974,810 | $1.51M | Insider |